Sartorius Stedim Biotech (SSB), a supplier for the biopharmaceutical industries, and GE Healthcare's Life Sciences business, a provider of technologies and services for biopharmaceutical manufacturing, have entered into a worldwide original equipment manufacturer (OEM) supply agreement for Sartorius Stedim Biotech's membrane adsorber purification technology, Sartobind.

Under the agreement, SSB will manufacture membrane adsorber technologies that will be marketed as part of GE's ReadyToProcess product offerings. Membrane adsorber ion-exchange technology is used for the removal of contaminants, such as endotoxins and viruses, during the production of protein-based drugs. Financial terms were not disclosed.

The new products will be marketed by GE under the brand “ReadyToProcess Adsorber.”

Source: Sartorius Stedim Biotech